(Q33364558)

English

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H J Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H M Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

T W Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M-H Ryu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H J Sohn

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

J H Yook

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S T Oh

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B S Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

J-S Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Y-K Kang

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

246-251

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chemotherapy in gastric cancer: a review and updated meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Capecitabine: preclinical pharmacology studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

How large should a phase II trial of a new drug be?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

21 June 2018

Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

21 January 2018

Docetaxel as salvage therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361863

31 October 2018

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin in patients with gastric cancer: a Cancer and Leukemia Group B phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin in the treatment of advanced gastric carcinoma: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15655540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602336

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6602336

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33364558&oldid=2195287966"